Vitality Vision

How do you make smart decisions when the future is uncertain?In this episode, Greg sits down with his co-hosts David Vogel (CEO) and Barry Miller (President) of Voloridge Investment Management and Voloridge Health, along with Lead Strategy Manager Daniel Hammack, for a conversation about how data science helps guide decisions in complex systems like financial markets and human health.Daniel shares his journey from being Voloridge Investment Management’s first intern to becoming a Lead Strategy Manager working on predictive modeling. The conversation also explores his experience placing second in a global competition predicting lung disease outcomes, offering an interesting bridge between modeling biological systems and financial markets.Together, the group spends most of the episode unpacking what data science actually is in plain English. They discuss how predictive models work, why probabilities matter more than certainty, and why a system that is right just slightly more than half the time can still produce powerful long-term results.They also explore the risks of groupthink in both finance and health, how data-driven thinking can challenge widely accepted narratives, and why improving the quality of decisions over time may be the most important edge we have.This is a thoughtful conversation about uncertainty, independent thinking, and how data science can help us make better decisions in an increasingly complex world.

In this powerhouse episode of Vitality Vision podcast, we’re joined by world-renowned neuroscientist Dr. Tommy Wood, just days after his appearances on The Tim Ferriss Show and The Joe Rogan Experience.Tommy sits down with Greg Bennett, David Vogel, and Barry Miller for a deep, wide-ranging conversation that unpacks the science and action steps behind his upcoming book, The Stimulated Mind (releasing March 2026 — pre-order here).This episode covers:Why brain health and cognitive decline must become a central focus in proactive careHow stress, resilience, and neuroplasticity shape long-term performanceThe most predictive biomarkers for dementia and how to test themData from Voloridge Health’s real-world research and what it’s revealingWhat “normal” vs. “optimal” really means in your health dataHow to take action, even late in life, to protect and improve brain functionWhether you’re a data geek, a healthspan enthusiast, or someone who simply wants to age with a sharp mind, this episode is packed with insights, practical takeaways, and cutting-edge science.Listen now,  and get ready to future-proof your brain.

In this powerful and inspiring episode, Greg and Barry sit down with world-class triathlete Timothy O’Donnell, whose athletic career includes podiums at the IRONMAN World Championships and years competing at the highest level of endurance sport. But Tim’s most remarkable story didn’t happen on a podium — it happened in the middle of a race, when he suffered a widowmaker heart attack, a condition with only a 12% survival rate. Tim not only survived — he came back stronger, and now uses his platform to advocate for proactive, preventative health.This episode explores Tim’s journey through elite sport, the day that changed his life forever, and the mindset he used to reset, reframe, and rebuild. You’ll hear how he’s shifted from purely performance-driven metrics to a deeper focus on healthspan, longevity, and monitoring key biomarkers.The conversation also brings Voloridge Health’s mission into focus — combining personal stories with our commitment to using data science and predictive scores to stay ahead of disease. We revisit the five biomarkers we believe everyone should track, and how insights from tools like Volo Age and Volo Scores are helping people take control of their health before symptoms even arise.Whether you're an athlete, a weekend warrior, or just someone looking to live longer and live better — this episode delivers insights, emotion, and a call to action.

In this episode of Vitality Vision, host Greg Bennett sits down with Voloridge Health President Barry Miller and CEO/Chief Science Officer David Vogel to reflect on a pivotal moment for the company — from a standout presence at the Eudemonia Longevity Summit to the road ahead in 2026. They break down the five biomarkers every health-conscious person should know — Cystatin C, HgbA1c, hsCRP, GGT, and ApoB — and why these often-overlooked metrics may be more powerful than the ones we’ve been trained to track. Along the way, they share how it felt to introduce Voloridge Health to the broader wellness world, what resonated most with attendees, and why this felt like a true "coming out moment" for the company.The conversation also explores Voloridge’s product evolution, scientific breakthroughs, and bigger mission: to shift healthcare from reactive to predictive, and give people the tools to live with energy, clarity, and purpose.Whether you're an early adopter of wearables and bloodwork, or just starting to explore your own health data, this episode delivers practical insight and big-picture perspective on where proactive health is going next.

In this episode of Vitality Vision by Volo, host Greg Bennett is joined by Voloridge Health’s CEO & CSO David Vogel and President Barry Miller for a conversation with Amy R. Mack, CEO of The Institute for Functional Medicine (IFM) — the leading voice for functional medicine for more than 30 years.   Amy’s leadership journey spans public service, nonprofit impact, and now functional medicine — where she’s on a mission to make personalized, root-cause care available to everyone, not just the elite few.  Together, we dive into: What functional medicine actually is — and how it differs from conventional care Amy’s personal journey and why she believes this movement matters now more than ever The work IFM is doing to train clinicians, influence policy, and expand access Why functional medicine is for everyone — not just biohackers or the wealthy What’s broken in our $4.5T healthcare system — and how to start fixing it Where the future of medicine is headed: AI, data science, systems biology & beyond A rapid-fire Underrated/Overrated segment on health trends like cold plunges, CGMs, and personalized supplements. We also reflect on what gives us hope, how to align incentives with prevention, and why 2026 should be the year we all double down on taking ownership of our health.  

Want to see the charts and references we mention? Watch the video version on YouTube!If you’ve ever been told you’re “pre-diabetic,” this episode is for you.We’re taught to watch our A1C — the main marker used to diagnose prediabetes and Type 2 diabetes — and many assume that if it’s below 5.7, we’re in the clear.But what if that’s not the whole story?In this episode of Vitality Vision by Volo, we explore groundbreaking findings from the Volo data team, based on over 28,000 individuals from the UK Biobank — all with the same A1C score of 5.7.Joining me are David Vogel (CEO and Chief Science Officer of Voloridge Health) and Barry Miller (President), as we unpack which biomarkers truly matter — and why A1C alone isn’t enough to assess your health.We break down the top predictors that separate the “healthy 5.7s” from the “unhealthy 5.7s,” including: BMI: The healthy group averaged 10 points lower HDL (good cholesterol): 18 points higher for men, 25 points higher for women SHBG (Sex Hormone-Binding Globulin): Doubled in the healthy group Urate: 1.5 points lower — linked to kidney and metabolic health ALT & GGT: Key liver enzymes, dramatically lower in the healthy cohort Triglycerides: Less than half the level of the unhealthy group CRP (C-reactive protein): A marker of inflammation — cut in half for men, and 75% lower in women LAR (Leptin-Adiponectin Ratio): Higher in the healthy group, a sign of better insulin sensitivity LDL: Slightly higher in the healthy group, but balanced when adjusting for cholesterol medication usage This podcast is not intended as medical advice. It is provided for educational and informational purposes only. The information provided is not intended diagnose, cure, mitigate, treat or prevent disease. Always discuss your health condition or any information presented herein with your health care provider.

Episode 7 may be our best conversation to date. We welcome our first-ever guest to Vitality Vision by Volo — Our exercise physiologist Tristan Starling-Smith, who brings a wealth of knowledge, clarity, and passion to the discussion. In this episode, we dive into what physiology really is and why it matters not only for elite athletes but for anyone who wants to live with more energy and health. Tristan walks us through the VoloClub Performance Lab and explains the tools of his trade — VO2 max, lactate testing, resting metabolic rate, body composition, and DARI motion capture — unpacking what each test measures, what insights they provide, and how actionable they are in practice. We explore how these protocols, once reserved for Olympians and professionals, are now being brought to the other 99% of people through the VoloClub. Tristan shares how everyday individuals — including those struggling with body fat, metabolic health, or simply wanting to feel better — can benefit from the same science that has guided champions. The conversation also connects physiology with data science and predictive health: how these measures feed into the development of the future Volo Scores, why waist circumference is more powerful than BMI, and how improving metrics like metabolic health isn’t just about disease avoidance but about feeling great, moving well, and improving quality of life. Along the way, David and Barry share their perspectives and experiences in the lab, including the role of biomarkers and how data-driven insights combine with hands-on testing to create a fuller picture of health. We finish with a lively round of overrated/underrated, where Tristan weighs in on cold plunges, saunas, Zone 2 training, VO2 max, lactate testing, and more. This episode captures the perfect blend of science, practicality, and fun — a conversation that sets the standard for everything we hope this podcast can be.

This episode opens with a celebration—Voloridge was named the Best Midsize Business to Work For in South Florida by the Sun Sentinel—and quickly shifts into one of the most impactful conversations yet. Greg, Barry, and David break down two of the most powerful (and misunderstood) markers of long-term health: A1C and ApoE protein. First, David unpacks the science behind A1C—a marker of long-term blood sugar regulation—and explains why it’s consistently showing up across our models as a strong predictor of disease. The team explores why even fit individuals can have high A1C, how it differs from insulin and glucose, and what actions can actually help lower it. Then, they turn to ApoE protein, a rising star in the world of cognitive health prediction. While many people know the ApoE gene, David explains why the protein may be even more valuable for early detection of cognitive decline—and how it connects to future offerings in the Volo platform. In this episode: What A1C really measures—and why it matters for metabolic and cardiac health How diet, exercise, CGMs, and stress affect A1C—and how to act on it Why the ApoE protein is showing promise beyond genetic testing The difference between genetics, epigenetics, and proteomics How we’re building tools to make this kind of insight available to everyone The conversation wraps with another round of underrated or overrated, where Greg, David, and Barry weigh in on everything from zone 2 cardio to CGMs and AI health coaches. This is a clear, candid, and deeply useful look at how data science is redefining what we can know—and what we can do—about our health.

In Episode 5 of Vitality Vision by Volo, we take a deep dive into one of the most overlooked but powerful health indicators: Cystatin C. Greg Bennett, Barry Miller, and David Vogel unpack what this biomarker is, why it matters, and how it compares to more traditional markers like creatinine when assessing kidney function and overall health risk.We explore how Cystatin C plays a critical role in the predictive models behind our proprietary Volo Health Scores, and how early changes in this marker can provide insight into longevity, metabolic health, and even cardiovascular risk—often well before symptoms appear.David walks us through the science, Barry shares real-world business implications, and Greg provides perspective from decades of elite-level sport and performance.We also update listeners on our journey building Voloridge Health—what’s new with the Volo App, what’s happening inside the Volo Club, and how our team is working to empower people with clarity, ownership, and action when it comes to their health.This episode is essential listening for anyone who wants to understand what’s really going on inside their body—and why standard lab panels might not be telling the full story.  Try out our Volo Simulator and explore our Blood Biomarker Reference Guide for free at https://voloridge.health/.Share your thoughts and questions with us at podcast@voloridgehealth.com.

"The ability to measure and assess health before decline occurs will be the greatest revolution of our time." – Fitness Insider Most people don’t think about their health until something goes wrong. In this episode of Vitality Vision by Volo, we discuss how we’re building the tools to change that—by making health as measurable and actionable as wealth. What’s broken in healthcare today? Why our models are 6x more accurate than traditional risk calculators How Volo Health Scores can help people take control of their health How we build a world-class data science team for health. Try out our Volo Simulator and explore our Blood Biomarker Reference Guide for free at https://voloridge.health/. Share your thoughts and questions with us at podcast@voloridgehealth.com.